Literature DB >> 21543325

Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.

Bernadine G C Lu1, Trifina Sofian, Ruby H P Law, Paul B Coughlin, Anita J Horvath.   

Abstract

α(2)-Antiplasmin is the physiological inhibitor of plasmin and is unique in the serpin family due to N- and C-terminal extensions beyond its core domain. The C-terminal extension comprises 55 amino acids from Asn-410 to Lys-464, and the lysine residues (Lys-418, Lys-427, Lys-434, Lys-441, Lys-448, and Lys-464) within this region are important in mediating the initial interaction with kringle domains of plasmin. To understand the role of lysine residues within the C terminus of α(2)-antiplasmin, we systematically and sequentially mutated the C-terminal lysines, studied the effects on the rate of plasmin inhibition, and measured the binding affinity for plasmin via surface plasmon resonance. We determined that the C-terminal lysine (Lys-464) is individually most important in initiating binding to plasmin. Using two independent methods, we also showed that the conserved internal lysine residues play a major role mediating binding of the C terminus of α(2)-antiplasmin to kringle domains of plasmin and in accelerating the rate of interaction between α(2)-antiplasmin and plasmin. When the C terminus of α(2)-antiplasmin was removed, the binding affinity for active site-blocked plasmin remained high, suggesting additional exosite interactions between the serpin core and plasmin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543325      PMCID: PMC3137029          DOI: 10.1074/jbc.M111.229013

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.

Authors:  Haiyao Wang; Anna Yu; Björn Wiman; Sarolta Pap
Journal:  Eur J Biochem       Date:  2003-05

2.  Murine serpin 2A is a redox-sensitive intracellular protein.

Authors:  Emma C Morris; Timothy R Dafforn; Sharon L Forsyth; Melinda A Missen; Anita J Horvath; Lynne Hampson; Ian N Hampson; Graeme Currie; Robin W Carrell; Paul B Coughlin
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  Measurement of the kinetic parameters mediating protease-serpin inhibition.

Authors:  Norman M Schechter; Michael I Plotnick
Journal:  Methods       Date:  2004-02       Impact factor: 3.608

4.  Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration.

Authors:  T A Morton; D G Myszka; I M Chaiken
Journal:  Anal Biochem       Date:  1995-05-01       Impact factor: 3.365

5.  Properties of three different molecular forms of the alpha 2 plasmin inhibitor.

Authors:  I Clemmensen; S Thorsen; S Müllertz; L C Petersen
Journal:  Eur J Biochem       Date:  1981-11

6.  Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.

Authors:  Zhonghui Lin; Longguang Jiang; Cai Yuan; Jan K Jensen; Xu Zhang; Zhipu Luo; Barbara C Furie; Bruce Furie; Peter A Andreasen; Mingdong Huang
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

7.  Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase.

Authors:  K N Lee; C S Lee; W C Tae; K W Jackson; V J Christiansen; P A McKee
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

8.  Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.

Authors:  Pascal S Frank; Justin T Douglas; Michael Locher; Miguel Llinás; Johann Schaller
Journal:  Biochemistry       Date:  2003-02-04       Impact factor: 3.162

9.  Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin.

Authors:  G L Hortin; B L Gibson; K F Fok
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

10.  The reactive site of human alpha 2-antiplasmin.

Authors:  B H Shieh; J Travis
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

View more
  10 in total

1.  The Rheumatoid Arthritis-Associated Citrullinome.

Authors:  Ronak Tilvawala; Son Hong Nguyen; Aaron J Maurais; Venkatesh V Nemmara; Mitesh Nagar; Ari J Salinger; Sunil Nagpal; Eranthie Weerapana; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2018-04-05       Impact factor: 8.116

Review 2.  Functions of the plasminogen receptor Plg-RKT.

Authors:  Lindsey A Miles; Juliana P Vago; Lirlândia P Sousa; Robert J Parmer
Journal:  J Thromb Haemost       Date:  2020-08-19       Impact factor: 5.824

3.  Identification of differentially expressed serum proteins in infectious purpura fulminans.

Authors:  Ting He; Jiong-yu Hu; Jian Han; Dong-xia Zhang; Xu-pin Jiang; Bing Chen; Yue-sheng Huang
Journal:  Dis Markers       Date:  2014-02-10       Impact factor: 3.434

Review 4.  Plasminogen Receptors and Fibrinolysis.

Authors:  Lindsey A Miles; Lina Ny; Malgorzata Wilczynska; Yue Shen; Tor Ny; Robert J Parmer
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

5.  Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.

Authors:  Satish Singh; Sofiyan Saleem; Guy L Reed
Journal:  Front Cardiovasc Med       Date:  2020-12-23

Review 6.  Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.

Authors:  Nikoletta Pechlivani; Katherine J Kearney; Ramzi A Ajjan
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

Review 7.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

8.  Altered behavior in mice with deletion of the alpha2-antiplasmin gene.

Authors:  Eri Kawashita; Yosuke Kanno; Kanako Ikeda; Hiromi Kuretake; Osamu Matsuo; Hiroyuki Matsuno
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

9.  Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.

Authors:  C Longstaff; M Locke
Journal:  J Thromb Haemost       Date:  2018-12-13       Impact factor: 5.824

10.  α2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline.

Authors:  Eri Kawashita; Keiichi Ishihara; Haruko Miyaji; Yu Tanishima; Akiko Kiriyama; Osamu Matsuo; Satoshi Akiba
Journal:  Mol Brain       Date:  2020-10-15       Impact factor: 4.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.